First Trust NYSE Arca Biotechnology Index Fund
245 hedge funds and large institutions have $717M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 92 reducing their positions, and 22 closing their positions.
490% more call options, than puts
Call options by funds: $1.83M | Put options by funds: $310K
41% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 22
1% more funds holding
Funds holding: 243 → 245 (+2)
5% less capital invested
Capital invested by funds: $751M → $717M (-$33.8M)
1.42% less ownership
Funds ownership: 50.92% → 49.5% (-1.4%)
45% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 92
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$7.73M |
| 2 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$5.49M |
| 3 |
Morgan Stanley
New York
|
+$4.97M |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$4.62M |
| 5 |
Jane Street
New York
|
+$4.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$16.9M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.57M |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$9.01M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$5.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.77M |
FBT Hedge Fund Activity: Q1 2023 in Review
245 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2023, worth a combined $717M — down 4.5% from $751M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FBT positions and 22 closed out — a net gain of 9 holders — while 51 added to existing stakes and 92 trimmed.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $7.73M. The largest seller was Bank of America, cutting an estimated $16.9M.
- 245 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2023, up from 243 in Q4 2022.
- Funds reported $717M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2023, down 4.5% quarter-over-quarter.
- 31 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2023 and 22 closed out, a net change of +9 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2023 was Raymond James Financial Services Advisors, an estimated $7.73M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2023 was Bank of America, an estimated $16.9M sold.
Based on aggregated 13F filings for Q1 2023.